
Gholam Reza Berenji MD
Clinical Professor, Radiological Sciences, UCLA School of Medicine
Join to View Full Profile
11301 Wilshire BlvdNuclear Medicine (115)Los Angeles, CA 90073
Phone+1 310-268-3547
Dr. Berenji is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical Center/VA Greater Los Angeles Healthcare SystemResidency, Nuclear Medicine, 2005 - 2007
- PIH Health Hospital - WhittierInternship, Transitional Year, 2004 - 2005
- Mashhad University of Medical SciencesClass of 1995
Certifications & Licensure
- CA State Medical License 2006 - 2026
- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Preventive Medicine Clinical Informatics
Clinical Trials
- F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets Start of enrollment: 2009 Jan 01
- A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. Start of enrollment: 2011 Jun 01
- 18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer Start of enrollment: 2020 Apr 07
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- Treatment Response Assessment According to Updated PROMISE Criteria in Patients with Metastatic Prostate Cancer Using an Automated Imaging Platform for Identification,...Cecil M Benitez, Hannicka Sahlstedt, Ida Sonni, Johan Brynolfsson, Gholam Reza Berenji
European Urology Oncology. 2024-11-08 - 2 citationsSystemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer.Nicholas G Nickols, Sonny Tsai, Nathanael Kane, Samantha Tran, Leila Ghayouri
European Urology. 2024-08-01 - Better Late than Never for Late Toxicity Assessment.Sai Duriseti, Gholam R Berenji, Nicholas G Nickols, Matthew B Rettig
European Urology. 2023-05-01
Press Mentions
- Open Clinical Trials for Patients with Prostate CancerMarch 10th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: